biotech
Recombinant Tuberculosis Vaccine
Filed in archive Drugs, Vaccines and Therapeutics by ruth on August 29, 2005
BlogPicture

In a paper published recently in the Journal of Clinical Investigations, Max Planck researchers revealed the mechanism by which the new genetically engineered tuberculosis (BCG) vaccine functions. The vaccine has been licensed to the Vakzine Projekt Management who will test it in clinical trials early 2006.

According to the press release, the recombinant BCG has shown more efficacy against tuberculosis in preclinical studies, and confers protection against clinical isolates of the Beijing family.
These clinical isolates are frequently multi-drug-resistant and more aggressive and hence have started to conquer the globe. It has been assumed that the Beijing isolates emerged in response to drug treatment and vaccination. The new genetically engineered BCG could provide an efficacious measure against this threat.


Permalink: Recombinant Tuberculosis Vaccine
Tags: vaccine  BCG  biotech  tuberculosis  recombinant  tuberculosis+vaccine  recombinant+tuberculosis  stem+cell 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/8788
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Recombinant Tuberculosis Vaccine:

  • Currently 6.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 6.50 out of 4 vote(s) cast.
 
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!